Atorvastatin HEC Pharm 10 mg Filmtabletten - Zusammengefasste Informationen

Dostupné balení:

Zusammenfassung der Merkmale des Arzneimittels - Atorvastatin HEC Pharm 10 mg Filmtabletten

PUBLIC ASSESSMENT REPORT

Decentralised Procedure

Gadothek

Procedure Number: DE/H/3378/001/DC

Gadopent

Procedure Number: DE/H/3379/0001/DC

Gadomed

Procedure Number: DE/H/3380/001/DC

Gadopur

Procedure Number: DE/H/3441/001/DC

Gadosan

Procedure Number: DE/H/3442/001/DC

Gadolan

Procedure Number: DE/H/3443/001/DC

Active Substance:Active Substance:

Gadopentetate Dimeglumine

Dosage Form:

Solution for injection / 0.5 mmol/ml

Marketing Authorisation Holder in the RMS, Germany:

medithek GmbH

Publication:

10.12.2021

This module reflects the scientific discussion for the approval of Gadothek; Gaodpent; Gadomed; Gadopur; Gadosan; Gadolan. The procedure was finalised on 23.01.2013.

TABLE OF CONTENTS

I. INTRODUCTION................................................................... Fehler! Textmarke nicht definiert.

Quelle: Original PDF (ema.europa.eu)